Orbimed Advisors - Q4 2021 holdings

$7.78 Billion is the total value of Orbimed Advisors's 159 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 25.6% .

 Value Shares↓ Weighting
SWTX  SPRINGWORKS THERAPEUTICS INC$373,634,000
-2.3%
6,028,3070.0%4.80%
+14.3%
BMY SellBRISTOL-MYERS SQUIBB CO$270,587,000
+1.3%
4,339,800
-3.9%
3.48%
+18.5%
HZNP SellHORIZON THERAPEUTICS PUB L$269,406,000
-5.8%
2,500,055
-4.2%
3.46%
+10.2%
BSX SellBOSTON SCIENTIFIC CORP$235,862,000
-6.8%
5,552,300
-4.8%
3.03%
+9.0%
NewTHESEUS PHARMACEUTICALS INC$213,514,00016,838,668
+100.0%
2.74%
EWTX  EDGEWISE THERAPEUTICS INC$213,075,000
-8.0%
13,944,6800.0%2.74%
+7.7%
MRTX BuyMIRATI THERAPEUTICS INC$209,239,000
-13.9%
1,426,400
+3.9%
2.69%
+0.7%
PMVP  PMV PHARMACEUTICALS INC$169,333,000
-22.5%
7,330,4230.0%2.18%
-9.3%
PFE NewPFIZER INC$154,439,0002,615,400
+100.0%
1.98%
 PRELUDE THERAPEUTICS INCnonvoting$148,660,000
-41.9%
11,895,6520.0%1.91%
-32.1%
HUM SellHUMANA INC$147,647,000
+13.3%
318,300
-5.0%
1.90%
+32.4%
ABBV SellABBVIE INC$144,716,000
-5.6%
1,068,800
-24.8%
1.86%
+10.5%
VRTX SellVERTEX PHARMACEUTICALS INC$144,519,000
-9.2%
658,100
-25.0%
1.86%
+6.2%
EW SellEDWARDS LIFESCIENCES CORP$139,422,000
+9.3%
1,076,200
-4.5%
1.79%
+27.9%
MRK SellMERCK & CO INC$136,366,000
-51.4%
1,779,300
-52.3%
1.75%
-43.1%
UNH SellUNITEDHEALTH GROUP INC$136,080,000
-10.6%
271,000
-30.5%
1.75%
+4.5%
ISRG BuyINTUITIVE SURGICAL INC$134,306,000
-3.2%
373,800
+167.8%
1.73%
+13.2%
NTRA SellNATERA INC$132,052,000
-24.7%
1,413,985
-10.1%
1.70%
-11.8%
ACET BuyADICET BIO INC$130,250,000
+129.7%
7,447,141
+3.0%
1.67%
+168.7%
ARQT  ARCUTIS BIOTHERAPEUTICS INC$125,972,000
-13.2%
6,073,8500.0%1.62%
+1.5%
PRLD  PRELUDE THERAPEUTICS INC$124,994,000
-60.2%
10,039,6910.0%1.61%
-53.4%
SYK BuySTRYKER CORPORATION$124,431,000
+39.8%
465,300
+37.9%
1.60%
+63.6%
GH  GUARDANT HEALTH INC$122,765,000
-20.0%
1,227,4000.0%1.58%
-6.4%
IOVA SellIOVANCE BIOTHERAPEUTICS INC$120,987,000
-26.2%
6,337,700
-4.6%
1.56%
-13.7%
XBI SellSPDR SER TRs&p biotech$113,046,000
-15.6%
1,009,700
-5.3%
1.45%
-1.3%
SGEN BuySEAGEN INC$101,356,000
+122.7%
655,600
+144.6%
1.30%
+160.6%
TPTX SellTURNING POINT THERAPEUTICS I$100,478,000
-35.9%
2,106,450
-10.8%
1.29%
-25.1%
HCA BuyHCA HEALTHCARE INC$100,070,000
+112.7%
389,500
+101.0%
1.29%
+148.9%
TCDA BuyTRICIDA INC$98,286,000
+120.3%
10,280,947
+6.9%
1.26%
+158.0%
KROS  KEROS THERAPEUTICS INC$98,263,000
+47.9%
1,679,4170.0%1.26%
+73.0%
CRNX BuyCRINETICS PHARMACEUTICALS IN$90,823,000
+44.0%
3,196,876
+6.7%
1.17%
+68.5%
MGTX SellMEIRAGTX HLDGS PLC$88,490,000
+63.6%
3,727,466
-9.2%
1.14%
+91.6%
DXCM SellDEXCOM INC$82,100,000
-34.2%
152,900
-32.9%
1.06%
-23.0%
NBIX SellNEUROCRINE BIOSCIENCES INC$79,371,000
-30.6%
931,915
-21.8%
1.02%
-18.8%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$76,059,000
+787.4%
860,880
+676.3%
0.98%
+940.4%
SVA  SINOVAC BIOTECH LTD$72,700,000
-7.3%
2,839,5000.0%0.94%
+8.5%
ZBH SellZIMMER BIOMET HOLDINGS INC$71,689,000
-25.9%
564,300
-14.6%
0.92%
-13.3%
RPTX  REPARE THERAPEUTICS INC$70,071,000
-19.6%
3,322,4880.0%0.90%
-5.9%
CMPX NewCOMPASS THERAPEUTICS INC$68,608,00021,642,975
+100.0%
0.88%
KNTE  KINNATE BIOPHARMA INC$68,185,000
-23.0%
3,847,9290.0%0.88%
-9.9%
TBPH BuyTHERAVANCE BIOPHARMA INC$66,019,000
+51.3%
5,974,535
+1.3%
0.85%
+77.2%
TMO SellTHERMO FISHER SCIENTIFIC INC$63,188,000
+0.3%
94,700
-14.1%
0.81%
+17.2%
ABCL  ABCELLERA BIOLOGICS INC$59,785,000
-28.6%
4,180,7680.0%0.77%
-16.5%
SBTX  SILVERBACK THERAPEUTICS INC$58,214,000
-33.3%
8,740,8870.0%0.75%
-22.0%
ALPN  ALPINE IMMUNE SCIENCES INC$56,530,000
+29.8%
4,081,5920.0%0.73%
+51.8%
JANX SellJANUX THERAPEUTICS INC$55,962,000
-25.4%
2,836,386
-18.2%
0.72%
-12.7%
BIIB SellBIOGEN INC$55,230,000
-16.7%
230,200
-1.7%
0.71%
-2.5%
SIBN BuySI-BONE INC$51,201,000
+6.3%
2,305,300
+2.5%
0.66%
+24.4%
ETNB  89BIO INC$48,744,000
-33.3%
3,729,4420.0%0.63%
-21.9%
GRCL  GRACELL BIOTECHNOLOGIES INCsponsored ads$47,625,000
-56.5%
7,884,8700.0%0.61%
-49.1%
PASG  PASSAGE BIO INC$44,214,000
-36.2%
6,962,8990.0%0.57%
-25.5%
SNDX BuySYNDAX PHARMACEUTICALS INC$43,371,000
+1090.9%
1,981,300
+939.5%
0.56%
+1295.0%
OSH SellOAK STR HEALTH INC$42,761,000
-24.3%
1,290,300
-2.9%
0.55%
-11.4%
XTNT  XTANT MED HLDGS INC$40,809,000
-49.6%
72,873,4940.0%0.52%
-40.9%
NPCE  NEUROPACE INC$40,444,000
-36.4%
4,012,2810.0%0.52%
-25.6%
GLPG SellGALAPAGOS NVspon adr$39,542,000
+3.9%
717,257
-0.9%
0.51%
+21.5%
TELA  TELA BIO INC$38,753,000
-6.3%
3,027,5420.0%0.50%
+9.7%
VRNA  VERONA PHARMA PLCsponsored ads$38,269,000
+22.6%
5,694,8410.0%0.49%
+43.4%
IKNA  IKENA ONCOLOGY INC$36,792,000
-0.6%
2,933,9410.0%0.47%
+16.2%
SEM SellSELECT MED HLDGS CORP$36,268,000
-21.1%
1,233,600
-3.0%
0.47%
-7.7%
SellADAGIO THERAPEUTICS INC$36,180,000
-84.1%
4,983,500
-7.4%
0.46%
-81.4%
ORIC  ORIC PHARMACEUTICALS INC$34,362,000
-29.7%
2,337,5740.0%0.44%
-17.7%
NSTG BuyNANOSTRING TECHNOLOGIES INC$34,084,000
+27.7%
807,100
+45.2%
0.44%
+49.5%
GHRS BuyGH RESEARCH PLCordinary shares$33,332,000
+5.8%
1,428,732
+0.0%
0.43%
+24.0%
SRRA  SIERRA ONCOLOGY INC$32,117,000
-0.8%
1,477,3200.0%0.41%
+16.0%
 CYTEK BIOSCIENCES INC$31,386,000
-23.8%
1,923,1390.0%0.40%
-10.8%
IMGN SellIMMUNOGEN INC$28,706,000
-66.0%
3,868,786
-74.0%
0.37%
-60.2%
MREO NewMEREO BIOPHARMA GROUP PLCads$27,624,00017,264,764
+100.0%
0.36%
TERN  TERNS PHARMACEUTICALS INC$26,804,000
-32.1%
3,791,2040.0%0.34%
-20.5%
PCVX BuyVAXCYTE INC$26,090,000
-0.6%
1,096,700
+6.0%
0.34%
+16.3%
EVH BuyEVOLENT HEALTH INCcl a$25,954,000
+142.7%
938,000
+171.9%
0.33%
+183.1%
SellERASCA INC$25,983,000
-43.5%
1,667,693
-23.1%
0.33%
-33.9%
VECT BuyVECTIVBIO HLDG AG$25,649,000
-35.2%
5,223,804
+2.0%
0.33%
-24.1%
NewVENTYX BIOSCIENCES INC$25,605,0001,289,280
+100.0%
0.33%
VTGN  VISTAGEN THERAPEUTICS INC$25,173,000
-28.8%
12,909,2830.0%0.32%
-16.7%
THC SellTENET HEALTHCARE CORP$24,425,000
+17.9%
299,000
-4.1%
0.31%
+37.7%
OMIC BuySINGULAR GENOMICS SYSTEMS IN$24,326,000
+8.8%
2,104,359
+5.3%
0.31%
+27.2%
SCPH  SCPHARMACEUTICALS INC$24,082,000
-24.5%
4,797,1480.0%0.31%
-11.7%
JNCE BuyJOUNCE THERAPEUTICS INC$23,880,000
+21.0%
2,859,900
+7.7%
0.31%
+41.5%
KDNY SellCHINOOK THERAPEUTICS INC$23,132,000
+27.6%
1,418,300
-0.2%
0.30%
+49.2%
DBTX  DECIBEL THERAPEUTICS INC$22,995,000
-39.7%
4,945,1920.0%0.30%
-29.4%
HARP BuyHARPOON THERAPEUTICS INC$21,921,000
+6.3%
2,903,508
+11.2%
0.28%
+24.2%
GILD  GILEAD SCIENCES INC$20,883,000
+4.0%
287,6000.0%0.27%
+21.3%
APLT BuyAPPLIED THERAPEUTICS INC$20,707,000
-44.7%
2,313,681
+2.5%
0.27%
-35.4%
XENE BuyXENON PHARMACEUTICALS INC$19,712,000
+170.4%
631,000
+32.3%
0.25%
+216.2%
LOGC  LOGICBIO THERAPEUTICS INC$19,558,000
-49.6%
8,466,7830.0%0.25%
-41.1%
GRPH BuyGRAPHITE BIO INC$19,463,000
-18.1%
1,565,812
+8.0%
0.25%
-4.2%
MRSN  MERSANA THERAPEUTICS INC$17,969,000
-34.0%
2,888,8470.0%0.23%
-22.7%
CMMB  CHEMOMAB THERAPEUTICS LTDsponsored ads$17,789,000
-37.7%
2,578,1740.0%0.23%
-27.1%
DHRPRB NewDANAHER CORPORATION5% conv pfd b$17,382,00010,000
+100.0%
0.22%
CRIS BuyCURIS INC$17,302,000
-37.3%
3,634,800
+3.2%
0.22%
-26.7%
ILMN NewILLUMINA INC$17,158,00045,100
+100.0%
0.22%
MIST  MILESTONE PHARMACEUTICALS IN$16,924,000
+14.7%
2,583,8210.0%0.22%
+34.6%
GMTX  GEMINI THERAPEUTICS INC$16,954,000
-28.0%
5,826,2240.0%0.22%
-15.8%
CRVS  CORVUS PHARMACEUTICALS INC$16,734,000
-50.2%
6,943,6540.0%0.22%
-41.7%
NXTC  NEXTCURE INC$16,266,000
-11.0%
2,711,0130.0%0.21%
+4.0%
CLDX SellCELLDEX THERAPEUTICS INC NEW$15,692,000
-29.8%
406,100
-2.0%
0.20%
-17.9%
BuyRXSIGHT INC$15,564,000
-1.7%
1,383,500
+10.7%
0.20%
+14.9%
FLDM SellFLUIDIGM CORP DEL$14,972,000
-50.6%
3,819,348
-17.0%
0.19%
-42.3%
SYBX  SYNLOGIC INC$14,593,000
-20.7%
6,029,9950.0%0.19%
-6.9%
ACRS BuyACLARIS THERAPEUTICS INC$14,335,000
+22.2%
985,900
+51.3%
0.18%
+42.6%
AGLE SellAEGLEA BIOTHERAPEUTICS INC$14,042,000
-56.0%
2,956,124
-26.4%
0.18%
-48.4%
CTMX BuyCYTOMX THERAPEUTICS INC$13,919,000
+50.1%
3,214,509
+76.4%
0.18%
+75.5%
LUNG  PULMONX CORP$13,950,000
-10.9%
435,0000.0%0.18%
+4.1%
BNR SellBURNING ROCK BIOTECH LTDsponsored ads$13,841,000
-58.3%
1,452,402
-21.8%
0.18%
-51.2%
FUSN  FUSION PHARMACEUTICALS INC$13,447,000
-47.3%
3,224,7700.0%0.17%
-38.4%
AMGN  AMGEN INC$12,846,000
+5.8%
57,1000.0%0.16%
+24.1%
CLXPF SellCYBIN INC$12,481,000
-57.6%
10,524,300
-21.7%
0.16%
-50.6%
CGEM SellCULLINAN ONCOLOGY INC$12,422,000
-52.0%
805,041
-29.8%
0.16%
-43.7%
GLTO  GALECTO INC$12,396,000
-15.6%
4,090,9370.0%0.16%
-1.2%
QURE  UNIQURE NV$12,145,000
-35.2%
585,5740.0%0.16%
-24.3%
BLU SellBELLUS HEALTH INC NEW$11,698,000
-21.8%
1,454,800
-40.7%
0.15%
-8.5%
NewSONENDO INC$11,337,0001,968,180
+100.0%
0.15%
NMTR Buy9 METERS BIOPHARMA INC$10,057,000
-9.7%
10,275,887
+20.0%
0.13%
+5.7%
MGTA BuyMAGENTA THERAPEUTICS INC$9,972,000
-27.6%
2,250,953
+18.9%
0.13%
-15.2%
RXDX  PROMETHEUS BIOSCIENCES INC$9,885,000
+66.8%
250,0000.0%0.13%
+95.4%
IMRA  IMARA INC$9,870,000
-44.9%
4,386,5680.0%0.13%
-35.5%
VOR  VOR BIOPHARMA INC$9,683,000
-25.9%
833,3330.0%0.12%
-13.9%
AFIB  ACUTUS MED INC$9,031,000
-61.4%
2,648,3860.0%0.12%
-54.9%
CVRX SellCVRX INC$8,843,000
-33.2%
723,055
-9.6%
0.11%
-21.4%
ACHL  ACHILLES THERAPEUTICS PLCsponsored ads$7,940,000
-35.7%
1,584,8450.0%0.10%
-25.0%
RAPT NewRAPT THERAPEUTICS INC$7,970,000217,000
+100.0%
0.10%
GOSS NewGOSSAMER BIO INC$7,725,000683,000
+100.0%
0.10%
GRAY  GRAYBUG VISION INC$7,619,000
-44.9%
4,163,3470.0%0.10%
-35.5%
OCX BuyONCOCYTE CORP$7,582,000
-25.4%
3,493,800
+22.3%
0.10%
-13.4%
NAUT  NAUTILUS BIOTECHNOLOGY INC$7,525,000
-15.6%
1,452,7740.0%0.10%
-1.0%
 NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0$7,172,000
-8.7%
6,000,0000.0%0.09%
+7.0%
AVTE  AEROVATE THERAPEUTICS INC$6,316,000
-43.8%
535,7140.0%0.08%
-34.7%
NTLA  INTELLIA THERAPEUTICS INC$6,290,000
-11.9%
53,2000.0%0.08%
+3.8%
SYRS  SYROS PHARMACEUTICALS INC$5,990,000
-27.1%
1,837,5000.0%0.08%
-14.4%
TARA BuyPROTARA THERAPEUTICS INC$5,607,000
+80.1%
830,641
+84.6%
0.07%
+111.8%
NRIX SellNURIX THERAPEUTICS INC$5,340,000
-69.2%
184,468
-68.1%
0.07%
-63.7%
SRPT SellSAREPTA THERAPEUTICS INC$5,286,000
-11.6%
58,700
-9.3%
0.07%
+3.0%
IMAB  I MABsponsored ads$5,266,000
-34.6%
111,1200.0%0.07%
-23.6%
HSAQ  HEALTH SCIENCES ACQ CORP 2$5,040,000
+1.9%
500,0000.0%0.06%
+20.4%
IPSC SellCENTURY THERAPEUTICS INC$4,870,000
-52.4%
307,047
-24.6%
0.06%
-44.2%
PHGE  BIOMX INC$4,502,000
-47.7%
2,813,4890.0%0.06%
-38.9%
ALXO BuyALX ONCOLOGY HLDGS INC$4,461,000
-59.7%
207,600
+38.4%
0.06%
-53.3%
IFRX SellINFLARX NV$4,166,000
+51.2%
875,297
-17.7%
0.05%
+80.0%
TALS  TALARIS THERAPEUTICS INC$3,780,000
+12.7%
247,2400.0%0.05%
+32.4%
 FIELD TRIP HEALTH LTD$3,722,000
-46.8%
1,538,4700.0%0.05%
-37.7%
INZY BuyINOZYME PHARMA INC$3,591,000
+5.4%
526,600
+79.1%
0.05%
+24.3%
 SIGHT SCIENCES INC$3,514,000
-22.6%
200,0000.0%0.04%
-10.0%
SellAADI BIOSCIENCE INC$3,082,000
-69.7%
127,600
-63.1%
0.04%
-64.3%
XFOR  X4 PHARMACEUTICALS INC$3,146,000
-56.7%
1,373,8490.0%0.04%
-50.0%
NewEXSCIENTIA PLCads$2,470,000125,000
+100.0%
0.03%
SURF SellSURFACE ONCOLOGY INC$2,237,000
-67.5%
467,945
-48.6%
0.03%
-61.8%
ASLN  ASLAN PHARMACEUTICALS LTDads$2,206,000
-37.1%
1,970,0000.0%0.03%
-28.2%
NewBRIGHT MINDS BIOSCIENCES INC$2,131,000660,600
+100.0%
0.03%
ADAG SellADAGENE INCads$2,123,000
-46.3%
263,176
-4.3%
0.03%
-37.2%
APTX BuyAPTINYX INC$2,001,000
+457.4%
749,500
+389.0%
0.03%
+550.0%
CBIO SellCATALYST BIOSCIENCES INC$1,581,000
-85.8%
1,729,402
-36.2%
0.02%
-83.6%
NewPYXIS ONCOLOGY INC$1,576,000143,640
+100.0%
0.02%
LABP  LANDOS BIOPHARMA INC$1,359,000
-67.1%
283,2170.0%0.02%
-62.2%
CABA  CABALETTA BIO INC$1,147,000
-68.8%
302,5090.0%0.02%
-62.5%
LBPH  LONGBOARD PHARMACEUTICALS IN$554,000
-44.8%
113,5000.0%0.01%
-36.4%
AUGX NewAUGMEDIX INC$278,00088,363
+100.0%
0.00%
NewOWLET INC*w exp 09/14/202$86,000220,704
+100.0%
0.00%
ExitOWLET INCcall$0-220,704
-100.0%
-0.00%
AZN ExitASTRAZENECA PLCcall$0-5,200
-100.0%
-0.00%
PHAS ExitPHASEBIO PHARMACEUTICALS INC$0-177,113
-100.0%
-0.01%
MAPSW ExitWM TECHNOLOGY INCcall$0-150,200
-100.0%
-0.01%
KZR ExitKEZAR LIFE SCIENCES INCcall$0-113,400
-100.0%
-0.01%
SBBP ExitSTRONGBRIDGE BIOPHARMA PLC$0-794,675
-100.0%
-0.02%
RGEN ExitREPLIGEN CORP$0-14,724
-100.0%
-0.05%
ExitPROCEPT BIOROBOTICS CORP$0-135,000
-100.0%
-0.06%
ExitAPTOSE BIOSCIENCES INC$0-2,594,348
-100.0%
-0.06%
NBTX ExitNANOBIOTIX SAsponsored ads$0-500,000
-100.0%
-0.06%
ExitOWLET INC$0-1,200,000
-100.0%
-0.07%
EVH ExitEVOLENT HEALTH INCcall$0-250,000
-100.0%
-0.08%
REGN ExitREGENERON PHARMACEUTICALS$0-13,560
-100.0%
-0.09%
CNVY ExitCONVEY HLDG PARENT INC$0-1,000,000
-100.0%
-0.09%
KALA ExitKALA PHARMACEUTICALS INC$0-3,438,998
-100.0%
-0.10%
NVAX ExitNOVAVAX INC$0-45,580
-100.0%
-0.10%
KZR ExitKEZAR LIFE SCIENCES INC$0-1,150,000
-100.0%
-0.11%
MAPS ExitWM TECHNOLOGY INC$0-700,400
-100.0%
-0.11%
ExitDICE THERAPEUTICS INC$0-440,000
-100.0%
-0.16%
FLXN ExitFLEXION THERAPEUTICS INC$0-2,769,383
-100.0%
-0.19%
ExitHUMACYTE INC$0-1,500,000
-100.0%
-0.19%
VRCA ExitVERRICA PHARMACEUTICALS INC$0-1,479,733
-100.0%
-0.20%
CTIC ExitCTI BIOPHARMA CORP$0-7,520,600
-100.0%
-0.24%
OLMA ExitOLEMA PHARMACEUTICALS INC$0-807,792
-100.0%
-0.24%
MREO ExitMEREO BIOPHARMA GROUP PLCads$0-17,264,764
-100.0%
-0.46%
CRSP ExitCRISPR THERAPEUTICS AGnamen akt$0-612,700
-100.0%
-0.75%
PGNY ExitPROGYNY INC$0-1,270,045
-100.0%
-0.78%
DCPH ExitDECIPHERA PHARMACEUTICALS IN$0-2,183,143
-100.0%
-0.82%
ANTM ExitANTHEM INC$0-207,100
-100.0%
-0.85%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

About Orbimed Advisors

Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.

Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.

The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.

Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.

Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BIOGEN INC42Q3 20235.0%
VERTEX PHARMACEUTICALS INC42Q3 20233.7%
THERMO FISHER SCIENTIFIC INC42Q3 20233.2%
SINOVAC BIOTECH LTD41Q3 20237.2%
NEUROCRINE BIOSCIENCES INC41Q3 20232.7%
BOSTON SCIENTIFIC CORP40Q3 20235.6%
BRISTOL-MYERS SQUIBB CO40Q2 20235.2%
AMGEN INC40Q3 20235.5%
INTUITIVE SURGICAL INC40Q3 20233.8%
GILEAD SCIENCES INC39Q3 20235.5%

View Orbimed Advisors's complete holdings history.

Latest significant ownerships (13-D/G)
Orbimed Advisors Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Ikena Oncology, Inc.September 21, 20232,189,1115.2%
Galecto, Inc.September 18, 2023749,5572.8%
PMV Pharmaceuticals, Inc.August 23, 20236,563,07713.5%
Gracell Biotechnologies Inc.August 11, 20237,641,5318.0%
Xtant Medical Holdings, Inc.August 03, 202373,114,59256.7%
Turnstone Biologics Corp.July 24, 20233,099,26513.4%
Passage BIO, Inc.June 29, 20238,034,00014.7%
Prelude Therapeutics IncMay 24, 202315,716,64228.6%
VectivBio Holding AGMay 24, 20235,156,5617.7%
Fusion Pharmaceuticals Inc.May 16, 20232,930,6704.6%

View Orbimed Advisors's complete significant-ownership history.

Latest filings
TypeFiled
32024-03-27
SC 13D/A2024-03-22
SC 13D/A2024-03-21
SC 13D/A2024-03-08
1442024-03-04
SC 13D/A2024-02-21
13F-HR2024-02-14
42024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Orbimed Advisors's complete filings history.

Compare quarters

Export Orbimed Advisors's holdings